Aryl Hydrocarbon Receptor–Dependent Pathways in Immune Regulation

American Journal of Transplantation

Volumn 16, Issue 8, 2016, Pages 2270-2276

  Gargaro, M ^a   Pirro, M ^b   Romani, R ^a   Zelante, T ^a   Fallarino, F ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Department of Medicine ^*  (Italy)

Author keywords

basic (laboratory) research science; cellular biology; clinical research practice; immune regulation; immunosuppression immune modulation; metabolism metabolite; tolerance

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR;

ACUTE PHASE RESPONSE; ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; DENDRITIC CELL; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; INNATE IMMUNITY; INTESTINE EPITHELIUM; LYMPHOCYTE; LYMPHOID CELL; MACROPHAGE; OUTCOME ASSESSMENT; POLLUTANT; PRIORITY JOURNAL; REVIEW; SKIN GRAFT; TH17 CELL; TRANSPLANTATION TOLERANCE;

EID: 85027916691     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13716     Document Type: Review

References (43)

1. Vogel CF, Khan EM, Leung PS, et al. Cross-talk between aryl hydrocarbon receptor and the inflammatory response: A role for nuclear factor-kappaB. J Biol Chem 2014; 289: 1866–1875.
2. Stockinger B, Di Meglio P, Gialitakis M, Duarte JH. The aryl hydrocarbon receptor: Multitasking in the immune system. Annu Rev Immunol 2014; 32: 403–432.
3. Nguyen NT, Hanieh H, Nakahama T, Kishimoto T. The roles of aryl hydrocarbon receptor in immune responses. Int Immunol 2013; 25: 335–343.
4. Kiss EA, Vonarbourg C, Kopfmann S, et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 2011; 334: 1561–1565.
5. Lee JS, Cella M, McDonald KG, et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat Immunol 2012; 13: 144–151.
6. Li Y, Innocentin S, Withers DR, et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 2011; 147: 629–640.
7. Ohtake F, Baba A, Takada I, et al. Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 2007; 446: 562–566.
8. Pallotta MT, Fallarino F, Matino D, Macchiarulo A, Orabona C. AhR-mediated, non-genomic modulation of IDO1 function. Front Immunol 2014; 5: 497.
9. Quintana FJ, Sherr DH. Aryl hydrocarbon receptor control of adaptive immunity. Pharmacol Rev 2013; 65: 1148–1161.
10. Bessede A, Gargaro M, Pallotta MT, et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 2014; 511: 184–190.
11. Wourms MJ, Sulentic CE. The aryl hydrocarbon receptor regulates an essential transcriptional element in the immunoglobulin heavy chain gene. Cell Immunol 2015; 295: 60–66.
12. Quintana FJ, Basso AS, Iglesias AH, et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008; 453: 65–71.
13. Veldhoen M, Hirota K, Westendorf AM, et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008; 453: 106–109.
14. Di Meglio P, Duarte JH, Ahlfors H, et al. Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions. Immunity 2014; 40: 989–1001.
15. Denison MS, Nagy SR. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 2003; 43: 309–334.
16. Zelante T, Iannitti RG, Cunha C, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 2013; 39: 372–385.
17. Zhang L, Nichols RG, Correll J, et al. Persistent organic pollutants modify gut microbiota-host metabolic homeostasis in mice through aryl hydrocarbon receptor activation. Environ Health Perspect 2015; 123: 679–688.
18. Hanash AM, Dudakov JA, Hua G, et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity 2012; 37: 339–350.
19. Kimura A, Naka T, Nakahama T, et al. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J Exp Med 2009; 206: 2027–2035.
20. Lawrence BP, Denison MS, Novak H, et al. Activation of the aryl hydrocarbon receptor is essential for mediating the anti-inflammatory effects of a novel low-molecular-weight compound. Blood 2008; 112: 1158–1165.
21. Opitz CA, Litzenburger UM, Sahm F, et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 2011; 478: 197–203.
22. Ball HJ, Jusof FF, Bakmiwewa SM, Hunt NH, Yuasa HJ. Tryptophan-catabolizing enzymes—party of three. Front Immunol 2014; 5: 485.
23. Denison MS, Yao EF. Characterization of the interaction of transformed rat hepatic cytosolic Ah receptor with a dioxin responsive transcriptional enhancer. Arch Biochem Biophys 1991; 284: 158–166.
24. Clark DA, Gauldie J, Szewczuk MR, Sweeney G. Enhanced suppressor cell activity as a mechanism of immunosuppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc Soc Exp Biol Med 1981; 168: 290–299.
25. Loverre A, Tataranni T, Castellano G, et al. IL-17 expression by tubular epithelial cells in renal transplant recipients with acute antibody-mediated rejection. Am J Transplant 2011; 11: 1248–1259.
26. Liu Z, Fan H, Jiang S. CD4(+) T-cell subsets in transplantation. Immunol Rev 2013; 252: 183–191.
27. Moreau A, Varey E, Bouchet-Delbos L, Cuturi MC. Cell therapy using tolerogenic dendritic cells in transplantation. Transplant Res 2012; 1: 13.
28. Cai LJ, Yu DW, Gao Y, Yang C, Zhou HM, Chen ZH. Activation of aryl hydrocarbon receptor prolongs survival of fully mismatched cardiac allografts. J Huazhong Univ Sci Technolog Med Sci 2013; 33: 199–204.
29. Hauben E, Gregori S, Draghici E, et al. Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. Blood 2008; 112: 1214–1222.
30. Punj S, Kopparapu P, Jang HS, et al. Benzimidazoisoquinolines: A new class of rapidly metabolized aryl hydrocarbon receptor (AhR) ligands that induce AhR-dependent Tregs and prevent murine graft-versus-host disease. PLoS One 2014; 9: e88726.
31. Mohinta S, Kannan AK, Gowda K, Amin SG, Perdew GH, August A. Differential regulation of Th17 and T regulatory cell differentiation by aryl hydrocarbon receptor dependent xenobiotic response element dependent and independent pathways. Toxicol Sci 2015; 145: 233–243.
32. Pauly SK, Fechner JH, Zhang X, Torrealba J, Bradfield CA, Mezrich JD. The aryl hydrocarbon receptor influences transplant outcomes in response to environmental signals. Toxicol Environ Chem 2012; 94: 1175–1187.
33. Nawrot TS, Vos R, Jacobs L, et al. The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation. Thorax 2011; 66: 748–754.
34. Wan F, Dai H, Zhang S, Moore Y, Wan N, Dai Z. Cigarette smoke exposure hinders long-term allograft survival by suppressing indoleamine 2, 3-dioxygenase expression. Am J Transplant 2012; 12: 610–619.
35. Haarer J, Johnson CL, Soeder Y, Dahlke MH. Caveats of mesenchymal stem cell therapy in solid organ transplantation. Transpl Int 2015; 28: 1–9.
36. Hinden L, Shainer R, Almogi-Hazan O, Or R. Ex vivo induced regulatory human/murine mesenchymal stem cells as immune modulators. Stem Cells 2015; 33: 2256–2267.
37. Jasperson LK, Bucher C, Panoskaltsis-Mortari A, Mellor AL, Munn DH, Blazar BR. Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality. Blood 2009; 114: 5062–5070.
38. Romani R, Pirisinu I, Calvitti M, et al. Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1. J Cell Mol Med 2015; 19: 1593–1605.
39. Hao K, Zhou Q, Chen W, et al. Possible role of the “IDO-AhR axis” in maternal-foetal tolerance. Cell Biol Int 2013; 37: 105–108.
40. Nguyen NT, Kimura A, Nakahama T, et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc Natl Acad Sci USA 2010; 107: 19961–19966.
41. Barratt-Boyes SM, Thomson AW. Dendritic cells: Tools and targets for transplant tolerance. Am J Transplant 2005; 5(12): 2807–2813.
42. Bankoti J, Rase B, Simones T, Shepherd DM. Functional and phenotypic effects of AhR activation in inflammatory dendritic cells. Toxicol Appl Pharmacol 2010; 246: 18–28.
43. Matino D, Gargaro M, Santagostino E, et al. IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII. J Clin Investig 2015; 125: 3766–3781.